이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2001. 12. 11.1 분 읽기
Draft Guidance for Industry on Integration of Dose-Counting Mechanisms Into MDI Drug Products; Availability
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Integration of Dose-Counting Mechanisms into MDI Drug Products." This draft guidance makes recommendations to manufacturers to incorporate dose-counters into metered-dose inhalers (MDIs) being developed for the treatment of lung diseases. The recommendations made in this draft guidance are intended to enhance the use of MDIs, specifically to help patients identify when MDIs are no longer delivering reliable doses.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →